Skip to main content

Table 1 Sensitization characteristics (per-protocol analysis)

From: Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

Sensitization Whole sample Responders Non-responders Withdrew p
  n % n % N % n %
n 279 100.0 161 57.7 48 17.2 70 25.1  
Monosensitization Alternaria 3 1.1 2 1.2 1 2.1 0 0.0 0.249
Monosensitization Aspergillus 12 4.3 6 3.7 1 2.1 5 7.1
Cats and dogs 22 7.9 14 8. 4 8.3 4 5.7
Molds, cats, and dogs 14 5.0 8 5.0 3 6.3 3 4.3
Molds 24 8.6 12 7.5 4 8.3 8 11.4
Mites, cats, and dogs 51 18.3 31 19.3 11 22.9 9 12.9
Mites and molds 32 11.5 14 8.7 4 8.3 14 20.0
Mites 70 25.1 37 23.0 16 33.3 17 24.3
Mites, molds, cats, and dogs 51 18.3 37 23.0 4 8.3 10 14.3
Polysensitization 51 18.3 37 23.0 4 8.3 10 14.3 0.043
Non-polysensitization 228 81.7 124 77.0 44 91.7 60 85.7
  1. Analysis: Chi squared test